AAAAAA

   
Results: 1-10 |
Results: 10
Call for a recommitment to clinical teaching
Authors: Porter, DD
Citation: Dd. Porter, Call for a recommitment to clinical teaching, ACAD MED, 76(11), 2001, pp. 1114-1115
Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
Authors: Prince, GA Denamur, F Deschamps, M Garcon, N Prieels, JP Slaoui, M Thiriart, C Porter, DD
Citation: Ga. Prince et al., Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease, VACCINE, 19(15-16), 2001, pp. 2048-2054
Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology - Reply
Authors: Prince, GA Mathews, A Curtis, SJ Porter, DD
Citation: Ga. Prince et al., Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology - Reply, J INFEC DIS, 183(9), 2001, pp. 1426-1427
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
Authors: Prince, GA Curtis, SJ Yim, KC Porter, DD
Citation: Ga. Prince et al., Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine, J GEN VIROL, 82, 2001, pp. 2881-2888
Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines
Authors: Ottolini, MG Porter, DD Hemming, VG Prince, GA
Citation: Mg. Ottolini et al., Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines, VIRAL IMMUN, 13(2), 2000, pp. 231-236
Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats
Authors: Prince, GA Capiau, C Deschamps, M Fabry, L Garcon, N Gheysen, D Prieels, JP Thiry, G Van Opstal, O Porter, DD
Citation: Ga. Prince et al., Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats, J VIROLOGY, 74(22), 2000, pp. 10287-10292
Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid
Authors: Prince, GA Mathews, A Curtis, SJ Porter, DD
Citation: Ga. Prince et al., Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid, J INFEC DIS, 182(5), 2000, pp. 1326-1330
Respiratory viral antigens in autopsy lung tissue specimens from patients with cancer or myocardial infarction
Authors: Porter, DD Porter, HG
Citation: Dd. Porter et Hg. Porter, Respiratory viral antigens in autopsy lung tissue specimens from patients with cancer or myocardial infarction, CLIN INF D, 29(2), 1999, pp. 437-440
Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model
Authors: Ottolini, MG Porter, DD Hemming, VG Zimmerman, MN Schwab, NM Prince, GA
Citation: Mg. Ottolini et al., Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model, BONE MAR TR, 24(1), 1999, pp. 41-45
Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)
Authors: Prince, GA Prieels, JP Slaoui, M Porter, DD
Citation: Ga. Prince et al., Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus), LAB INV, 79(11), 1999, pp. 1385-1392
Risultati: 1-10 |